Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial
Author: B Yulug, O Altay, X Li, L Hanoglu et al.
Year Published: 2025
Media Outlet: Brain Communications
Open Access? Yes
Matrix: Plasma and Serum
Biological Themes: Neurological function
Product(s): Global Discovery Panel
Cited in over 3,000 publications, we help scientists and manufacturers gain greater insight into their studies through metabolomics.
GET STARTED
Talk with an expert
Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.
Find us on:
